CS
ZLAB icon

Candriam SCA’s Zai Lab ZLAB Stock Holding History

Candriam SCA’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-238,897
Closed -$8.35M – 701
2025
Q2 		$8.35M Sell
238,897
-2,044
-0.8% -$67.2K 0.05% 275
2025
Q1 		$8.71M Sell
240,941
-134,538
-36% -$4.14M 0.05% 259
2024
Q4 		$9.83M Sell
375,479
-14,544
-4% -$404K 0.06% 263
2024
Q3 		$9.41M Buy
390,023
+25,010
+7% +$473K 0.05% 278
2024
Q2 		$6.33M Sell
365,013
-170,000
-32% -$2.99M 0.04% 309
2024
Q1 		$8.57M Buy
535,013
+210,000
+65% +$4.42M 0.05% 272
2023
Q4 		$8.88M Buy
+325,013
New +$8.58M 0.06% 266
2022
Q1 		– Sell
-107,546
Closed -$6.76M – 853
2021
Q4 		$6.76M Buy
107,546
+3,231
+3% +$274K 0.04% 303
2021
Q3 		$11M Buy
104,315
+38,667
+59% +$5.55M 0.07% 257
2021
Q2 		$13.2M Buy
65,648
+65,643
+1,312,860% +$10.6M 0.09% 245
2021
Q1 		$1K Buy
+5
New +$774 ﹤0.01% 804

Other funds holding ZLAB

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Candriam SCA's ZLAB Position: Q3 2025 in Review

Candriam SCA sold out of Zai Lab (ZLAB) in Q3 2025, closing a stake of 238,897 shares — an estimated $8.35M sold.

Candriam SCA first reported a position in ZLAB in Q1 2021 and held it in 11 quarters. The position peaked at $13.2M in Q2 2021. 138 funds tracked by Wall St. Rank hold ZLAB as of Q3 2025.

  • Candriam SCA reported no remaining Zai Lab position as of Q3 2025 after selling out during the quarter.
  • Candriam SCA sold 238,897 Zai Lab shares in Q3 2025, an estimated $8.35M.
  • Candriam SCA first reported a position in Zai Lab in Q1 2021 and held it in 11 quarters.
  • Candriam SCA's Zai Lab position peaked at $13.2M in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Zai Lab as of Q3 2025.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.